| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0068 | 0.9 |